Monday May 25, 2020

Knowledge is power with new cancer test

26th August, 2018
David Corr, chief executive, Atturos Pic: Liam Blake

Medtech start-up Atturos is preparing to bring to market a blood test that could help men diagnosed with prostate cancer avoid undergoing unnecessary surgery. “The lead product we have in development is a test for men who have been diagnosed with low to intermediate prostate cancer,” said David Corr, chief executive of Atturos. “They have to decide whether to opt for surgery and radiotherapy or go on to an active surveillance programme. These treatment options...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 3 weeks ago

What’s coming up today and what you might have missed

Hannah O’Brien | 5 months ago